Somerset Indus At A Glance

Total Funds
Fully Exited
Partners' Cumulative
0+ Years
Sustainable Development
Goals Served

About Somerset Indus

Somerset Indus is a healthcare focused private equity firm making private equity and equity-related investments primarily in growth-oriented healthcare companies in India.

Somerset Indus Healthcare Fund was founded in 2011 by Avinash Kenkare, a private equity professional with 20+ years of successful investing experience in healthcare; and Somerset Indus Healthcare India Fund by Mayur Sirdesai, a healthcare/ pharma professional with over 20+ years of experience in the Indian Pharma/ Healthcare Industry across private equity, operational and consulting services.

In 2018, Somerset Indus setup its second Fund. The team was strengthened by bringing on board two new partners. Kannan Ramesh with 25 years’ experience in healthcare delivery and fundraising and Sharad Ladha with 20 years’ experience in private equity, consulting and insurance related experience.

Somerset Indus aims to invest in healthcare delivery product and service platforms run by experienced healthcare entrepreneurs which are focused on providing quality and affordable healthcare across India, especially in the lower tier markets. Somerset Indus through its investment thesis of profitable and sustainable impact based investing has been supporting capacity build up and aims to deliver accessibility and affordability to healthcare in India with a key focus on creating a positive impact on the environment, society, and governance.

The team uses its successful private equity investment experience, healthcare systems knowledge, in depth India specific healthcare experience and knowledge base to make investments in Indian healthcare companies and deploys the capital successfully to grow businesses and increase profitability. The firm believes in following a disciplined approach towards investing and makes all efforts to support the portfolio companies as well as potential investee companies in terms of operational support, accesses to our healthcare networks, talent acquisition and support on strategic and execution related matters of the companies.


“To partner with healthcare entrepreneurs and help in providing the right impetus operationally and financially, to increase availability, accessibility, affordability and provide quality healthcare to the underserved and privileged India also using technology as an enabler”


“To become the preferred strategic, operational and financial partner of choice in the healthcare sector in India and to grow to size and scale in pre dominantly tier II, tier III markets”

Key Differentiators

  • A team of investment professionals having extensive knowledge, relationships with domestic players, access to and experience dealing with global participants that can bring new technologies and provide access to new markets
  • Active handholding as first institutional investors
  • Extensive fund engagement with portfolio companies in areas of portfolio expansion, talent acquisition and strategy and operational aspects
  • Active involvement of external networks to add value to portfolio companies
  • Strong focus on ESG and sustainable impact investing across the investment cycle
  • Capturing the strong deal flow opportunities of the SME space especially in the recession resistant healthcare sector in India

Our Story Timeline

Cool Timeline

January 2011


Fund Formed by Avinash Kenkare and Mayur Sirdesai

May 2011


Sandor Medicaids Investment

July 2012


Express Clinics Investment

March 2013


Cygnus Medicare Investment

February 2014


Prognosys Medical Systems Investment

October 2014


Express Clinics Exit

July 2015


Krsnaa Diagnostics Investment

November 2015


Browndove Healthcare Investment

January 2016


Sandor Medicaids Exit

November 2016


Hexagon Nutrition Investment

February 2017


ESG theme incorporated

January 2018


Fund II Fundraising Starts

May 2019


Apex Hospitals Investment

May 2019


Genworks Health Investment

November 2019

November 2019

Cygnus Hospitals Partial Exit

August 2021

August 2021

Krsnaa Diagnostics Partial Exit

September 2021

September 2021

Globela Pharma Investment

June 2022

June 2022

Sterling Hospitals Investment


The Fund makes controlling or influential minority investments in small and mid-sized Indian companies in the healthcare services and products sector.